Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Find out which savings strategy is most effective for your financial goals. Implement these strategies for better savings.
26,213 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A 73-year-old retiree with $1.6 million in a traditional 401(K) confronts a sizable first required minimum distributi...
If Rivian hits the sweet spot with the R2, the stock story could change in meaningful ways. This guide breaks down wh...
A dramatic intraday rise in The Trade Desk shares grabbed headlines. This article breaks down the catalysts, what the...
Alibaba.com's leader previews a future where a single founder can run a global B2B business with AI handling the heav...
As bitcoin oscillates, MSTY investors confront a structural risk tied to the ETF’s option strategy. The fund’s income...
Pricing power has long been Apple’s ace. Now the company faces a no-win pricing trap: raise prices risking demand, or...
A 68-year-old with $850,000 traditional IRA could face a six-figure tax bill as required minimum distributions loom. ...
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
Shield AI's new CEO asserts the company is at a pivotal moment, as its battlefield-tested drones and software shift f...
As e.l.f. Beauty moves into 2026, investors want clarity on growth drivers and risk. This guide breaks down the Q4 ou...
A tech founder explains why he dismissed roughly 80% of his team after AI resistance and what it means for workers an...